November 1, 2012
According to results of a study by researchers at the University of California, San Francisco (UCSF), African American women co-infected with HIV and the hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women. The study examined racial differences and mortality among women co-infected with HIV and HCV.
The team followed 794 patients who were part of the Women's Interagency HIV study funded by the National Institutes of Health. The patient group included 140 Caucasians, 159 Hispanics, and 495 African Americans. The patients were seen twice a year for detailed health histories, physical exams, interviews, and clinical tests. At median follow-up of approximately 9 years and maximum follow-up of 16 years, there were 438 deaths, 37 percent from HIV/AIDS and 11 percent from liver-related disease. About 56 percent of African-Americans, 56 percent of Caucasians, and 52 percent of Hispanics died during follow-up.
Liver disease was the primary cause of death in 21 percent of Hispanics, 14 percent of Caucasians, and 8 percent of African-Americans. Dr. Monika Sarkar, the lead researcher, noted that further studies are needed to understand the reasons for the discrepancy in liver-related deaths among these racial groups.
The study titled, "Lower Liver-Related Death in African-American Women With Human Immunodeficiency Virus/Hepatitis C Virus Coinfection, Compared to Caucasian and Hispanic Women," was published in the journal Hepatology, 56: 1699-1705. doi: 10.1002/hep.25859.
Infection Control Today
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|HIV Vaccine Induces Sustained HIV Remission in Proof-of-Concept Study|
|Incidence of All Cancers but Lung Cancer Drops After HIV Group Stops Smoking|
|What's Your Message to the Trump Administration About the Fight Against HIV?|
|New HIV Capsid Inhibitor Strongly Stops HIV Replication at Two Steps|
|Classic Risk Factors Drive Heart Attack Rates More Than HIV Variables|
|Antibody Therapies Effective at Preventing HIV From Invading CD4 Cells|